Among its other interests Wyatt has an outfit called Firesmart which advises on fire certification. Fire certification is to be made the responsibility of the individual company (no longer can you seek the advice of the Fire Brigade) Has anyone any knowledge of Wyatts Firesmart activities and how much they could be augmented by new regulations, due to commentce in mid 2005?

A passing reference in, I think, SHARES,to the possibility of WYATT buying a new drug detector business. Anyone know anyfink.

When I first wrote on this board, they were 19p. No interest whatsoever. Today they are paying 37p for em. What does it take to stir you folk up?

Today saw Wyatt shares rise 140% - just because they say "they expect to make a profit"...well, that is the general idea!
It seems quite odd that this statement alone, should push the sp so much and I wait for it to fall-back, at least until the Market can work out what the business is really worth - a couple of years of profits, maybe a dividend etc.
I understand this is a "consultancy business" - which by any standard is difficult to assess - until the figures are published. + I don't hold this one.

WYATT GROUP PLC AND ITS SUBSIDIARY UNDERTAKINGS

PRELIMINARY RESULTS ANNOUNCEMENT FOR THE YEAR ENDED
31 March 2007



I am delighted to report on what has been a significant year in the Group's
development. It is a pleasure to be able to announce that the Group made an
operating profit before joint venture, amortisation and interest of #353,662
compared to a loss last year of #541,571. This was on a turnover of #2,990,863
(2006: #1,296,149) which represents an increase of 131%. The profit attributable
to shareholders (after amortisation, depreciation, interest, joint venture
interests, minority interests and tax was #121,589 (2006: #687,280 loss).



Operations



The Group's principal subsidiaries are Risksmart Limited, Premier Employer
Solutions Limited ('PES') and Wyatt Biotech Limited.



Risksmart provides an on-line fire risk assessment solution for small and medium
sized businesses. The long awaited Fire Safety legislation became effective on
1st October 2006. This has been the turning point that the team were awaiting
and Risksmart is now close to trading profitably on a month on month basis. This
is just reward for the management team who have worked hard to build the
foundations despite the continued set-backs that the considerable delays in
implementing the legislation have presented.



PES provides a range of employment related consultancy and support services
focused around human resources, reward and employment tax. It has made
significant progress in 2006/07 and has continued to develop its range of
products and services and to build on its impressive client base. The results
for the year ended 31 March 2007 are excellent with the company generating a
profit for the year after tax. PES is currently marketing a tax product that has
proved tremendously successful, generating significant revenues and giving it
access to a number of high profile blue chip clients. The management team are
reinvesting much of the revenues generated from this product into building and
expanding the core business activities of PES. The beginning of the current
financial year has already been encouraging and we are confident of yet another
strong performance.



Wyatt Biotech is the Group's drug testing operation. It has been a long and
frustrating year for this business. There have been unforeseen delays in the
testing and production of the drug testing product, resulting in it still not
being ready to commence market trials. I believe that if these issues can be
overcome then there is an exciting future for this business. However, in the
short term the Group is taking steps to limit further funding for ongoing costs.
It is intended that these costs will instead be met by the US inventor/developer
who will inject funds into the business to bring the product up to the point
where it can be taken to market. In return, the company will become a joint
venture between Wyatt and the US inventor. I believe that this course of action
is in the best interests of our shareholders.



Prospects



This is a fantastic turnaround for the Group and hopefully indicates to
shareholders that their continued patience and belief will be rewarded in the
future. I would like to thank everybody involved in Wyatt for their hard work
and dedication. We have now built a platform for growth and with continued hard
work we will be able to take Wyatt to the next level.



R Holt
Chairman
11 July 2007

This was on a turnover of #2,990,863 (2006: #1,296,149) which represents an increase of 131%. The profit attributable to shareholders (after amortisation, depreciation, interest, joint venture interests, minority interests and tax was #121,589 (2006: #687,280 loss).
Well undervalued IMHO, at only 1.8m MCAP.

Turnover more than doubled, 687k loss to 121k maiden profit!

The share price has been to 40p twice before, and then it was on hope of good turnover, and profit... now we have proof that all the component parts are viable, and can look forward to building on those increses in net profit, and turnover.
40p would still only be under 5 mil mcap...I'm in with 5,000 shares!

Wyatt Group swings to FY pretax profit on higher turnover UPDATE

(Adds details on PES unit)
LONDON (Thomson Financial) - Wyatt Group PLC swung to a full-year pretax
profit on a 131 pct rise in turnover and said that it is confident of a strong
performance in the current year for its PES consulting unit.
The UK consultancy services group posted a pretax profit of 108,201 stg for
the year to March 31, 2007 against a loss of 717,259 stg last year. Turnover
rose to 2.97 mln stg from 1.26 mln a year ago.
The company said its biotech business experienced unforeseen delays in the
testing and production of the drug testing product, resulting in it not being
ready to begin market trials.
The group is therefore taking steps to limit further funding for ongoing
costs and it is intended that the costs will instead be met by the US
inventor/developer. In return, Wyatt Biotech will become a joint venture between
Wyatt and the US inventor, it added.
Wyatt said its PES unit has made significant progress in 2006/07 and has
continued to develop its range of products and services. PES is currently
marketing a tax product, generating significant revenues and giving it access to
several blue-chip clients.

14.00-18.00 pence, started rising now. IMO the Interims produced a spike to 23 pence, the results out today should produce a spike to the 30 pence levels at the very least! The Normal Market Size is only 500 shares so all the trades are delayed in reporting by 2 hours!

Some good size delayed buys have come through and more tick ups just now. Should get some good press mentions tomorrow IMO. Very undervalued at the moment!

Good close with a 36% rise on back of excellent results today! Onwards and upwards tomorrow IMO. All the delayed buys will be trickling through. Delayed in reporting by 2 hours!

Annualised profits with a P/e of 20 and tax of 30% gives a price of 36.7p. The share price therefore has the potential to nearly double.

After Close: British Bulls.

BUY-IF

19.000
+5.0000 +35.

Wyatt Group PLC
Daily Commentary

Our system posted a BUY-IF today. The previous SELL recommendation was made on 10.05.2007 (63) days ago, when the stock price was 18.0000. Since then WYT has gained 5.56% .
http://www.britishbulls.com/StockPage.asp?CompanyTicker=WYT&MarketTicker=Financials&TYP=S

Daily Express Newspaper today.
Share Whisper....CONSULTANCY firm Wyatt Group rose 5p to 19p yesterday as it turned a previous annual loss of 541,571 into profits of 353,662 in 2006. It has secured a joint venture funding deal for its drug-testing business and there is speculation it is is lining up a international acquisition.

Daily Mail Newspaper today.
WYATT Group soared 5p to 19p in celebration of a strong return to profitability last year. The UK consultancy services group achieved a pretax profit of 108,201 against a loss of 717,259 last time. Turnover jumped 131pc to 2.99m. Analysts will now be busily upgrading full-year forecasts. An earnings enhancing acquisition in the employment-related consultancy and support services field could be on the agenda soon.

Up 10% already and with lots of more good news to come in the coming days, these remain a v.strong buy IMO!